Stanford University

Showing 1,221-1,230 of 14,493 Results

• Jason Bloom

  Undergraduate, Hasso Plattner Institute of Design
  Printshop Assistant, d.school
  

  • Contact Info

    Mail Code: 3086

    jbloom0@stanford.edu
• Paul Bloom

  Temporary Employee (Nonexempt), SLAC National Accelerator Laboratory
  

  • Contact Info

    • 2575 Sand Hill Rd
    • Mailstop 0011
    • Menlo Park, California 94025

    Mail Code: 11

    • (650) 926-4041 (office)

    paul.bloom@stanford.edu
• Taylor May Bloomfield

  Master of Arts Student in Philosophy, admitted Autumn 2022
  Grad Oral Comm Tutor, Hume Center
  

  • Contact Info

    Mail Code: 2085

    taylormb@stanford.edu
• 

  Zaeda Blotner

  Immigrant Child Health Program Administrator, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
  

  Current Role at StanfordImmigrant Child Health Program Administrator
• Martin Christopher Blue

  Masters Student in Symbolic Systems, admitted Autumn 2022
  Democracy & Disagreement Peer Facilitator, Ethics In Society
  

  • Contact Info

    Mail Code: 2150

    blue25c@stanford.edu
• William M Blue

  Health Physics Technician III, SLAC National Accelerator Laboratory
  

  • Contact Info

    • 2575 Sand Hill Rd
    • Mailstop 0048
    • Menlo Park, California 94025

    Mail Code: 0210

    bblue@stanford.edu

  • Other Names:

    Billy Blue
• 

  Ayame Misaki Bluebell

  Life Science Research Professional 1, Ophthalmology Research/Clinical Trials
  

  • Contact Info

    Mail Code: 5353

    ayablue@stanford.edu
• Jennifer Casebeer Blum

  Assistant Dean of Admission for Marketing, Events and Yield, UGA
  

  • Contact Info

    jenblum@stanford.edu

  • Other Names:

    Jen Blum

    Jen Casebeer

    Jennifer Casebeer
• 

  Mr Mark Blumling

  Lecturer, Law Teaching
  

  BioMark Blumling is an Executive Advisor at New Mountain Capital. Mark is the former CEO and Founder of Headlands Research, a KKR-backed clinical research site company. Mark was previously CEO and Co-Founder of Genos, a big data healthcare technology company (acquired in 2017) and CEO of Relevare Pharmaceuticals, a pharmaceutical company based in San Francisco and Melbourne, Australia. Prior to joining Relevare, Mark was Founder and COO of Hyperion Therapeutics (NASDAQ: HPTX; acquired in 2015) as well as a Director at Burrill & Company, where he worked in private equity, venture capital, and investment banking. Mark began his career in the Office of Science & Technology (R&D) at SmithKline Beecham, where he was involved in the creation and development of new business ventures, and at Orchid Biosciences (NASDAQ: ORCH).
  
  Mark received a JD from Stanford Law School, an MSc (Economics) from the London School of Economics, and a BA in Human Biology from Stanford University. He is a Member of the Council on Foreign Relations.

  • Contact Info

    Mail Code: 8610

  • Web page:

    https://www.linkedin.com/in/markblumling/
• Teleya Blunt

  Women'S Tennis Camp Counselor, Women's Tennis Program
  

  • Contact Info

    Mail Code: 6150